Tags

Type your tag names separated by a space and hit enter

Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer.
Gynecol Endocrinol 2014; 30(12):868-71GE

Abstract

While the field of oncofertility raised awareness about fertility concerns in oncology patients, new applications for fertility preservation are emerging, such as transgender medicine. As transgender medicine evolves, the number of individuals seeking gender reassignment hormone therapy is drastically increasing, generating a population of patients with unmet fertility needs and unknown reproductive potential. We present the first case report of a female-to-male (FtM) transgender patient to undergo oocyte cryopreservation before initiating androgen therapy. Our patient is a 17-year-old FtM transgender person undergoing gender transition throughout adolescence with an endocrinologist. The patient wished to complete androgen therapy before starting his first year of college to avoid gender ambiguity. After extensive consultation and psychological assessment, the patient was considered an appropriate candidate and proceeded with oocyte cryopreservation. He underwent baseline fertility testing followed by successful ovarian stimulation and surgical retrieval. We recommend that a discussion of reproductive health concerns and fertility preservation options be incorporated into the comprehensive care of transgender patients.

Authors+Show Affiliations

a Department of Obstetrics and Gynecology.a Department of Obstetrics and Gynecology.a Department of Obstetrics and Gynecology. b Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Colorado Denver Aurora, CO USA.

Pub Type(s)

Case Reports
Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

25254620

Citation

Wallace, Sumer Allensworth, et al. "Fertility Preservation in the Transgender Patient: Expanding Oncofertility Care Beyond Cancer." Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, vol. 30, no. 12, 2014, pp. 868-71.
Wallace SA, Blough KL, Kondapalli LA. Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecol Endocrinol. 2014;30(12):868-71.
Wallace, S. A., Blough, K. L., & Kondapalli, L. A. (2014). Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 30(12), pp. 868-71. doi:10.3109/09513590.2014.920005.
Wallace SA, Blough KL, Kondapalli LA. Fertility Preservation in the Transgender Patient: Expanding Oncofertility Care Beyond Cancer. Gynecol Endocrinol. 2014;30(12):868-71. PubMed PMID: 25254620.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. AU - Wallace,Sumer Allensworth, AU - Blough,Kiara L, AU - Kondapalli,Laxmi A, Y1 - 2014/09/25/ PY - 2014/9/26/entrez PY - 2014/9/26/pubmed PY - 2016/10/14/medline KW - Fertility preservation KW - oocyte cryopreservation KW - transgender man KW - transgender medicine SP - 868 EP - 71 JF - Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology JO - Gynecol. Endocrinol. VL - 30 IS - 12 N2 - While the field of oncofertility raised awareness about fertility concerns in oncology patients, new applications for fertility preservation are emerging, such as transgender medicine. As transgender medicine evolves, the number of individuals seeking gender reassignment hormone therapy is drastically increasing, generating a population of patients with unmet fertility needs and unknown reproductive potential. We present the first case report of a female-to-male (FtM) transgender patient to undergo oocyte cryopreservation before initiating androgen therapy. Our patient is a 17-year-old FtM transgender person undergoing gender transition throughout adolescence with an endocrinologist. The patient wished to complete androgen therapy before starting his first year of college to avoid gender ambiguity. After extensive consultation and psychological assessment, the patient was considered an appropriate candidate and proceeded with oocyte cryopreservation. He underwent baseline fertility testing followed by successful ovarian stimulation and surgical retrieval. We recommend that a discussion of reproductive health concerns and fertility preservation options be incorporated into the comprehensive care of transgender patients. SN - 1473-0766 UR - https://www.unboundmedicine.com/medline/citation/25254620/Fertility_preservation_in_the_transgender_patient:_expanding_oncofertility_care_beyond_cancer_ L2 - http://www.tandfonline.com/doi/full/10.3109/09513590.2014.920005 DB - PRIME DP - Unbound Medicine ER -